On Watch For Breakout In Shares Of Intercept Pharmaceuticals Inc

Discussion in 'Stock Market Forum' started by inthemoneystocks, Dec 20, 2017.

  1. Chartman

    Chartman Senior Investor

    Joined:
    Sep 2017
    Posts:
    247
    Likes Received:
    5
    Is the sector back in favour? Are investors looking to increase their risk profiles in exchange for potentially greater rewards? Perhaps a switch from some of the "new tech" stocks?
     
  2. JR Ewing

    JR Ewing Super Moderator Staff Member

    Joined:
    Feb 2014
    Posts:
    4,917
    Likes Received:
    39
    These biotechs (not to be conflated with the big pharma stocks) are well suited for the "bottom-up" investing if one can tolerate the added risk. Although they tend to be more volatile than the broad markets in most cases, most of their movement (up or down) is based upon what happens with their drugs - clinical trials, FDA decisions, etc... and somewhat on M&A activity and speculation as well.

    I sold half of my LOXO this morning at ~ $165 for a nice profit on such good news: https://seekingalpha.com/article/41...s-cimzia-trial-success-audentes-positive-data
     
  3. JR Ewing

    JR Ewing Super Moderator Staff Member

    Joined:
    Feb 2014
    Posts:
    4,917
    Likes Received:
    39

Share This Page